CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 215 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,055,744 | +22.4% | 38,750 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $862,188 | +2.7% | 38,750 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $839,325 | +10.2% | 38,750 | +3.3% | 0.00% | 0.0% |
| Q4 2022 | $761,625 | +6.1% | 37,500 | +33.9% | 0.00% | 0.0% |
| Q3 2022 | $718,000 | -22.0% | 28,000 | -27.7% | 0.00% | 0.0% |
| Q2 2022 | $921,000 | +5.5% | 38,750 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $873,000 | +13.8% | 38,750 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $767,000 | -55.4% | 38,750 | -55.7% | 0.00% | -75.0% |
| Q3 2021 | $1,720,000 | -10.6% | 87,400 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,923,000 | -5.6% | 87,400 | +2.1% | 0.00% | 0.0% |
| Q1 2021 | $2,036,000 | +48.8% | 85,600 | +63.7% | 0.00% | +33.3% |
| Q4 2020 | $1,368,000 | +128.0% | 52,300 | +51.6% | 0.00% | +50.0% |
| Q3 2020 | $600,000 | +3.4% | 34,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $580,000 | +41.5% | 34,500 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $410,000 | – | 34,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |